Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132490) titled 'A randomized controlled study on the enhanced efficacy of thalidomide in the treatment of low-risk mucous membrane pemphigoid' on Sept. 15.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: West China Hospital of Stomatoloy, Sichuan University

Condition: Mucous membrane pemphigoid

Intervention: Experimental group:On the basis of standard treatment (topical glucocorticoids), take 50mg of thalidomide orally every day

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2026-02-02

Target Sample Size: Experimental group:18;Control group:18;

Countries of Recruitme...